Standard BioTools Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $3.16 on 09/01/23, while the lowest price for the same duration was marked at $1.46 on 05/04/23.
52-week price history of LAB Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Standard BioTools Inc’s current trading price is -23.42% away from its 52-week high, while its distance from the 52-week low is 65.75%. The stock’s price range during this period has spanned from $1.46 to $3.16. In the Healthcare sector, the Standard BioTools Inc’s shares surpassed a trading volume of approximately 2.33 million for the day, which was noticeably higher compared to the average daily volume of 9.2.05 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Standard BioTools Inc (LAB) has experienced a quarterly rise of 3.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 926.98M and boasts a workforce of 539 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.43, with a change in price of -0.09. Similarly, Standard BioTools Inc recorded 1,908,879 in trading volume during the last 100 days, posting a change of -3.59%.
Examining LAB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.60. Similarly, the long-term debt-to-equity ratio is also 0.21.
LAB Stock Stochastic Average
Today’s raw stochastic average for Standard BioTools Inc over the last 50 days is 23.46%.This indicates a increase from the raw stochastic average of the past 20 days, which was 3.12%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 9.37% and 9.41%, respectively.
LAB Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 9.50%. However, over the past six months, we’ve seen a weaker performance of 14.69%. The price of LAB leaped by -10.37% over the last 30 days. And in the last five days, it has fallen by -7.28%.
